Save time and get answers to complex questions with AI chat
Does lipitor's use influence blood pressure medication type?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Patent expiry trametinib?Generic brand for latisse?Patent expiration eu dabrafenib?
See the DrugPatentWatch profile for nivolumab
Nivolumab is produced by Bristol Myers Squibb. The company manufactures and markets Opdivo (nivolumab) as an anti–PD-1 immune checkpoint inhibitor.
In many markets, nivolumab is sold under the brand name Opdivo by Bristol Myers Squibb.
Information about additional producers (such as biosimilar or alternative suppliers) depends on the country and whether an approved biosimilar is available there. DrugPatentWatch.com can help track manufacturers and related patent/legal status by product and jurisdiction. Sources: 1. DrugPatentWatch.com – Nivolumab (Opdivo)
Other Questions About Nivolumab :